CancerVAX is an early-stage oncology drug development company working on developing a universal cancer vaccine and a therapeutic for Ewing sarcoma.
| Website | http://www.cancervax.com |
| Employees | 12 (5 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Oncology Drug Development, Immunotherapy, Cancer Therapeutics, Vaccine Development, Cancer Research, Oncology Research, Cancer Treatment, Innovative Cancer Therapies, Clinical Stage Oncology, Therapeutic Development, Novel Therapeutics, Drug Discovery, Biotechnology, Pharmaceutical Research, Sarcoma Treatment, Clinical Trials |
| Competitors | Merck & Co., Inc., Bayer, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Moderna Therapeutics, CureVac, Aduro Biotech is now Chinook Therapeutics +31 more (view full list) |
Looking for a particular CancerVAX employee's phone or email?
Byron Elton is the President and CEO of CancerVAX.
5 people are employed at CancerVAX.